30 Apr NOVACYT FULL YEAR 2018 RESULTS
Paris, France and Camberley, UK – 30 April 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its audited financial results for the...
Paris, France and Camberley, UK – 30 April 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its audited financial results for the...
Paris, France et Camberley, UK – 25 avril 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), spécialiste international du diagnostic clinique, annonce qu'il prévoit désormais de publier ses résultats audités pour l'exercice clos...
Paris, France and Camberley, UK – 25 April 2019 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, announces that it now intends to report its audited results for the full...
Paris, France et Camberley, UK – 23 avril 2019 - Novacyt (EURONEXT GROWTH : ALNOV; AIM: NCYT), spécialiste international du diagnostic clinique se félicite d'annoncer qu'elle a conclu un programme...
Paris, France and Camberley, UK – 23 April 2019 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is pleased to announce that it has entered...
Paris, France et Camberley, Royaume-Uni – le 8 avril 2019 – Novacyt (EURONEXT GROWTH : ALNOV ; AIM : NCYT), spécialiste mondial du diagnostic clinique annonce aujourd’hui que sa division de tests...
Paris, France and Camberley, UK – 8 April 2019 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its molecular testing division, Primerdesign Ltd....
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers https://novacyt.com/wp-content/uploads/2019/04/NOVACYT_CP_Droits-de-vote_2019-Apr.pdf ...
Paris, France and Camberley, UK – 1 April 2019 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, today announces its monthly update in relation to ordinary shares...
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers https://novacyt.com/wp-content/uploads/2019/03/Contrat-de-liquidité-1-mars-2019.pdf ...
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |